049960 — Cell Biotech Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSuper Stock

Annual balance sheet for Cell Biotech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	ARS	ARS	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	57,834	65,368	70,332	87,454	93,012
Net Total Accounts Receivable
Net Total Receivables	5,217	5,336	6,397	4,980	5,389
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	67,519	75,655	81,929	97,148	103,712
Net Property, Plant And Equipment	34,057	33,638	32,937	30,463	30,460
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	112,877	115,839	117,641	130,398	136,572
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5,766	7,389	4,821	5,863	4,861
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	6,189	7,747	5,755	6,229	4,936
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	106,687	108,092	111,885	124,168	131,637
Total Liabilities & Shareholders' Equity	112,877	115,839	117,641	130,398	136,572
Total Common Shares Outstanding